Novel peptides of the respiratory syncytial virus (RSV) G proteinand their use in a vaccine

Details for Australian Patent Application No. 2002336148 (hide)

Owner Pierre Fabre Medicament

Inventors Beck, Alain; Plotnicky, Helene; Corvaia, Nathalie; Nguyen Ngoc, Thien

Agent Freehills

Pub. Number AU-B-2002336148

PCT Number PCT/FR02/02599

PCT Pub. Number WO2003/010317

Priority 01/09731 20.07.01 FR

Filing date 19 July 2002

Wipo publication date 17 February 2003

Acceptance publication date 13 December 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/155 (2006.01) Medicinal preparations containing antigens or antibodies - Paramyxoviridae, e.g. parainfluenza virus

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 14/135 (2006.01) Peptides having more than 20 amino acids

C07K 14/15 (2006.01) Peptides having more than 20 amino acids

C07K 16/10 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/45 (2006.01) Mutation or genetic engineering

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

20 February 2003 Complete Application Filed

  Priority application(s): 01/09731 20.07.01 FR

29 May 2003 Application Open to Public Inspection

  Published as AU-B-2002336148

13 December 2007 Application Accepted

  Published as AU-B-2002336148

10 April 2008 Standard Patent Sealed

19 June 2008 Corrigenda

  Applications Accepted - Name Index Under the Name Pierre Fabre Medicament, Application No. 2002336148, under INID (54), correct the title of the application to Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine

17 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002336149-METHOD FOR CONTROLLING IGNITION PARAMETERS OF A SPARK PLUG FOR INTERNAL COMBUSTION ENGINE

2002336147-ENVELOPE OR PACKET TYPE PACKAGE FOR MAILING